IBD RECO

The chart shows the growth of an initial investment of $10,000 in IBD RECO, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Jul 11, 2019, IBD RECO's average daily return is +0.03%, while the average monthly return is +0.63%. At this rate, your investment would double in approximately 9.2 years.

Historically, 65% of months were positive and 35% were negative. The best month was Jul 2022 with a return of +7.2%, while the worst month was Mar 2020 at -7.3%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 3 months.

On a daily basis, IBD RECO closed higher 52% of trading days. The best single day was Apr 6, 2020 with a return of +4.1%, while the worst single day was Mar 16, 2020 at -4.7%.

IBD RECO has an annualized alpha of 0.97%, beta of 0.49, and R² of 0.79 versus S&P 500 Index. Calculated based on daily prices since July 11, 2019.

• This portfolio participated in 67.75% of S&P 500 Index downside but only 56.21% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.49 indicates this portfolio moves significantly less than S&P 500 Index — a genuinely defensive profile with reduced participation in both market rallies and downturns.

IBD RECO has an expense ratio of 0.79%, placing it in the medium range. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

IBD RECO ranks 19 for risk / return — in the bottom 19% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

IBD RECO Sharpe ratios as of Apr 3, 2026 (values are recalculated daily):

• 1-Year: 0.82
• 5-Year: 0.53
• All Time: 0.66

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.98 to 1.66, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of IBD RECO compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

IBD RECO provided a 1.81% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the IBD RECO. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the IBD RECO was 19.74%, occurring on Mar 23, 2020. Recovery took 94 trading sessions.

The current IBD RECO drawdown is 3.09%.

The chart below shows the rolling one-month volatility.